Literature DB >> 22890996

Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae.

Angela E Reeves1, Mark J Koenigsknecht, Ingrid L Bergin, Vincent B Young.   

Abstract

The indigenous microbial community of the gastrointestinal (GI) tract determines susceptibility to Clostridium difficile colonization and disease. Previous studies have demonstrated that antibiotic-treated mice challenged with C. difficile either developed rapidly lethal C. difficile infection or were stably colonized with mild disease. The GI microbial community of animals with mild disease was dominated by members of the bacterial family Lachnospiraceae, while the gut community in moribund animals had a predominance of Escherichia coli. We investigated the roles of murine Lachnospiraceae and E. coli strains in colonization resistance against C. difficile in germfree mice. Murine Lachnospiraceae and E. coli isolates were cultured from wild-type mice. The ability of each of these isolates to interfere with C. difficile colonization was tested by precolonizing germfree mice with these bacteria 4 days prior to experimental C. difficile challenge. Mice precolonized with a murine Lachnospiraceae isolate, but not those colonized with E. coli, had significantly decreased C. difficile colonization, lower intestinal cytotoxin levels and exhibited less severe clinical signs and colonic histopathology. Infection of germfree mice or mice precolonized with E. coli with C. difficile strain VPI 10463 was uniformly fatal by 48 h, but only 20% mortality was seen at 2 days in mice precolonized with the Lachnospiraceae isolate prior to challenge with VPI 10463. These findings confirm that a single component of the GI microbiota, a murine Lachnospiraceae isolate, could partially restore colonization resistance against C. difficile. Further study of the members within the Lachnospiraceae family could lead to a better understanding of mechanisms of colonization resistance against C. difficile and novel therapeutic approaches for the treatment and prevention of C. difficile infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890996      PMCID: PMC3486043          DOI: 10.1128/IAI.00647-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Phylogenetic relationships of butyrate-producing bacteria from the human gut.

Authors:  A Barcenilla; S E Pryde; J C Martin; S H Duncan; C S Stewart; C Henderson; H J Flint
Journal:  Appl Environ Microbiol       Date:  2000-04       Impact factor: 4.792

2.  Colonization resistance of the digestive tract of mice during systemic antibiotic treatment.

Authors:  D van der Waaij; J M Berghuis; J E Lekkerkerk
Journal:  J Hyg (Lond)       Date:  1972-12

3.  Colonization resistance of the digestive tract in conventional and antibiotic-treated mice.

Authors:  D van der Waaij; J M Berghuis-de Vries
Journal:  J Hyg (Lond)       Date:  1971-09

4.  Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters.

Authors:  J G Bartlett; A B Onderdonk; R L Cisneros; D L Kasper
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

Review 5.  Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology.

Authors:  P G Falk; L V Hooper; T Midtvedt; J I Gordon
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

6.  Clindamycin-induced colitis.

Authors:  R Fekety; J Silva; R A Browne; G D Rifkin; J R Ebright
Journal:  Am J Clin Nutr       Date:  1979-01       Impact factor: 7.045

7.  Inhibition of Clostridium difficile strains by intestinal Lactobacillus species.

Authors:  Paul Naaber; Imbi Smidt; Jelena Štšepetova; Tatjana Brilene; Heidi Annuk; Marika Mikelsaar
Journal:  J Med Microbiol       Date:  2004-06       Impact factor: 2.472

8.  Suppression of Clostridium difficile by normal hamster cecal flora and prevention of antibiotic-associated cecitis.

Authors:  K H Wilson; J Silva; F R Fekety
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

9.  New strategies for cultivation and detection of previously uncultured microbes.

Authors:  Bradley S Stevenson; Stephanie A Eichorst; John T Wertz; Thomas M Schmidt; John A Breznak
Journal:  Appl Environ Microbiol       Date:  2004-08       Impact factor: 4.792

10.  Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro.

Authors:  Mark J Hopkins; George T Macfarlane
Journal:  Appl Environ Microbiol       Date:  2003-04       Impact factor: 4.792

View more
  142 in total

Review 1.  Gastrointestinal dysbiosis and the use of fecal microbial transplantation in Clostridium difficile infection.

Authors:  L Patrick Schenck; Paul L Beck; Justin A MacDonald
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 2.  Considering the Immune System during Fecal Microbiota Transplantation for Clostridioides difficile Infection.

Authors:  Alyse L Frisbee; William A Petri
Journal:  Trends Mol Med       Date:  2020-02-17       Impact factor: 11.951

Review 3.  Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns.

Authors:  E G Pamer
Journal:  Mucosal Immunol       Date:  2014-01-08       Impact factor: 7.313

4.  The Intestinal Microbiota Influences Campylobacter jejuni Colonization and Extraintestinal Dissemination in Mice.

Authors:  Jason L O'Loughlin; Derrick R Samuelson; Andrea G Braundmeier-Fleming; Bryan A White; Gary J Haldorson; Jennifer B Stone; Jeremy J Lessmann; Tyson P Eucker; Michael E Konkel
Journal:  Appl Environ Microbiol       Date:  2015-05-01       Impact factor: 4.792

5.  Toxin-positive Clostridium difficile latently infect mouse colonies and protect against highly pathogenic C. difficile.

Authors:  Lucie Etienne-Mesmin; Benoit Chassaing; Oluwaseyi Adekunle; Lisa M Mattei; Frederic D Bushman; Andrew T Gewirtz
Journal:  Gut       Date:  2017-02-20       Impact factor: 23.059

6.  Human milk oligosaccharides shorten rotavirus-induced diarrhea and modulate piglet mucosal immunity and colonic microbiota.

Authors:  Min Li; Marcia H Monaco; Mei Wang; Sarah S Comstock; Theresa B Kuhlenschmidt; George C Fahey; Michael J Miller; Mark S Kuhlenschmidt; Sharon M Donovan
Journal:  ISME J       Date:  2014-02-13       Impact factor: 10.302

Review 7.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

Review 8.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

Review 9.  Clostridium difficile colitis: pathogenesis and host defence.

Authors:  Michael C Abt; Peter T McKenney; Eric G Pamer
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

10.  Commensal Gram-positive bacteria initiates colitis by inducing monocyte/macrophage mobilization.

Authors:  Y Nakanishi; T Sato; T Ohteki
Journal:  Mucosal Immunol       Date:  2014-06-18       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.